PMID: 6164338Jan 1, 1981Paper

The protein antigens of peripheral nerve myelin

Annals of Neurology
J N Whitaker

Abstract

Peripheral nervous system (PNS) tissue contains a variety of proteins, lipids, and carbohydrates that may serve as immunogens in proving immune responses, as antigens participating in immunological reactions, or as both types of agents. Three proteins P0, P1, and P2, account for approximately 70% of PNS myelin proteins. P0 is the major PNS myelin protein and is restricted to the PNS. P1 is similar to, if not identical with, myelin basic protein, the component of central nervous system myelin which induces experimental allergic encephalomyelitis. P2 has neuritogenic properties for inducing experimental allergic neuritis and may be involved in immune-mediated PNS myelin injury in humans. The complete amino acid sequence for P2 has recently been delineated, and its neuritogenic, immunogenic, and antigenic features can now be further characterized.

References

Feb 27, 1975·Biochimica Et Biophysica Acta·K KitamuraK Uyemura
Aug 1, 1977·The Journal of Experimental Medicine·J N WhitakerR F Kibler
Jul 1, 1977·Journal of Neurochemistry·K UyemuraK Kitamura
Aug 1, 1977·Journal of the Neurological Sciences·J R McDermott, H M Wiśniewski
Aug 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·E BarbareseJ H Carson
Jun 1, 1978·Journal of Neurochemistry·C W ShultsJ G Wood
Dec 1, 1978·The Journal of Cell Biology·R K LiemM L Shelanski
Feb 1, 1975·Journal of Neurochemistry·S W BrostoffC DiPaola
Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·B D TrappH D Webster
Jun 24, 1977·Biochimica Et Biophysica Acta·J M SeyerJ N Whitaker
May 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·N H SternbergerH D Webster
Jul 5, 1979·The New England Journal of Medicine·D J ProckopN A Guzman
Apr 1, 1979·Neurochemical Research·E H EylarS Greenfield
Apr 1, 1978·The Journal of Cell Biology·P Sherline, K Schiavone
May 1, 1978·Journal of Neurochemistry·S Micko, W W Schlaepfer
Sep 1, 1978·The Journal of Cell Biology·W W Schlaepfer, L A Freeman
Sep 26, 1978·Biochimica Et Biophysica Acta·M W RoomiE H Eylar
Sep 26, 1978·Biochimica Et Biophysica Acta·M W Roomi, E H Eylar
Mar 24, 1977·Nature·J P BrockesM C Raff
Sep 1, 1977·The Journal of Experimental Medicine·D E TrenthamA H Kang
Jul 19, 1976·Biochimica Et Biophysica Acta·G H De VriesM G Hadfield
Dec 23, 1976·The New England Journal of Medicine·S R CohenG M McKhann
Jun 26, 1975·Biochimica Et Biophysica Acta·O Abramsky, Y London
May 16, 1975·Brain Research·R C WigginsP Morell
Nov 1, 1972·Journal of Neurochemistry·K UyemuraY Tsukada
Nov 1, 1974·Journal of Neurochemistry·S W BrostoffH Wisniewski
Jul 1, 1974·The Biochemical Journal·P R Dunkley, P R Carnegie
Dec 5, 1973·Biochimica Et Biophysica Acta·J M MatthieuH de F Webster
May 1, 1974·Journal of Neurochemistry·J G Wood, R M Dawson
Dec 1, 1972·Archives of Biochemistry and Biophysics·S W Brostoff, E H Eylar
Apr 1, 1973·Journal of Neurochemistry·S GreenfieldP Morell

❮ Previous
Next ❯

Citations

Jul 1, 1990·Journal of Neuroscience Research·A C LeBlanc, J F Poduslo
Jun 1, 1983·Italian Journal of Neurological Sciences·J N Whitaker
Nov 26, 1990·Brain Research·L T Wang-BennettG N Bennett
Oct 1, 1983·Journal of the Neurological Sciences·L G EpsteinC S Raine
Jul 1, 1993·Journal of the Neurological Sciences·T OlssonH Link
Nov 1, 1994·Journal of the Neurological Sciences·S L WatsonJ D Pollard
Apr 26, 2003·Journal of Structural Biology·Jan SedzikPaolo Riccio
Jun 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M C FrankoD C Gajdusek
Aug 1, 1995·The Journal of Experimental Medicine·S Abromson-LeemanM E Dorf
May 20, 1998·Pathology International·H AraiY Nakazato
Dec 1, 1986·Agents and Actions·C LiningtonR Meyermann
Oct 1, 1984·Neurochemical Research·J N Whitaker, J M Seyer
Jan 1, 1984·Journal of Neurochemistry·D J Nunn, C Mezei
Apr 1, 1986·Acta Neurologica Scandinavica·S Dhib-Jalbut, B H Liwnicz
Mar 23, 1999·The Annals of Otology, Rhinology, and Laryngology·H MatsuokaT J Yoo
Jul 1, 1988·Journal of Child Neurology·J Willis, P Van den Bergh
Sep 1, 1992·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·R AmitS Meyeir
Apr 1, 1986·Annals of Neurology·J BurnsD Pleasure
Feb 12, 1987·The New England Journal of Medicine·T HemachudhaP Phanuphak
May 1, 1988·Drug and Alcohol Dependence·L PastenaA Ceddia
May 1, 1982·Annals of Neurology·H L Weiner, S L Hauser

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.